Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms.

Kelly DL, Sullivan KM, McEvoy JP, McMahon RP, Wehring HJ, Gold JM, et al. Adjunctive Minocycline in Clozapine-Treated Schizophrenia Patients With Persistent Symptoms. J Clin Psychopharmacol. 2015;35(4):374-81. DOI: 10.1097/JCP.0000000000000345. PubMed PMID: 26082974.

Association of the HTR2A 102T/C polymorphism with attempted suicide: a meta-analysis.

Wang J-Y, Jia C-X, Lian Y, Sun S-H, Lyu M, Wu A. Association of the HTR2A 102T/C polymorphism with attempted suicide: a meta-analysis. Psychiatr Genet. 2015;25(4):168-77. DOI: 10.1097/YPG.0000000000000091. PubMed PMID: 26075944.

Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial.

Kane JM, Zukin S, Wang Y, Lu K, Ruth A, Nagy K, et al. Efficacy and Safety of Cariprazine in Acute Exacerbation of Schizophrenia: Results From an International, Phase III Clinical Trial. J Clin Psychopharmacol. 2015;35(4):367-73. DOI: 10.1097/JCP.0000000000000346. PubMed PMID: 26075487.

Treating Schizophrenia With 2 Long-Acting Injectable Antipsychotic Drugs: A Case Report.

Wartelsteiner F, Hofer A. Treating Schizophrenia With 2 Long-Acting Injectable Antipsychotic Drugs: A Case Report. J Clin Psychopharmacol. 2015;35(4):474-5. DOI: 10.1097/JCP.0000000000000358. PubMed PMID: 26075490.

Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge.

Doshi JA, Pettit AR, Stoddard JJ, Zummo J, Marcus SC. Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital Discharge. J Clin Psychopharmacol. 2015;35(4):442-6. DOI: 10.1097/JCP.0000000000000353. PubMed PMID: 26075492.

Shared reduction of oscillatory natural frequencies in bipolar disorder, major depressive disorder and schizophrenia.

Canali P, Sarasso S, Rosanova M, Casarotto S, Sferrazza-Papa G, Gosseries O, et al. Shared reduction of oscillatory natural frequencies in bipolar disorder, major depressive disorder and schizophrenia. J Affect Disord. 2015;184:111-5. DOI: 10.1016/j.jad.2015.05.043. PubMed PMID: 26074020.

PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome.

de Koning MB, van Duin EDA, Boot E, Bloemen OJN, Bakker JA, Abel KM, et al. PRODH rs450046 and proline x COMT Val¹⁵⁸ Met interaction effects on intelligence and startle in adults with 22q11 deletion syndrome. Psychopharmacol (berl). 2015;232(17):3111-22. DOI: 10.1007/s00213-015-3971-5. PubMed PMID: 26068888.

CACNA1C gene and schizophrenia: a case-control and pharmacogenetic study.

Porcelli S, Lee S-J, Han C, Patkar AA, Serretti A, Pae C-U. CACNA1C gene and schizophrenia: a case-control and pharmacogenetic study. Psychiatr Genet. 2015;25(4):163-7. DOI: 10.1097/YPG.0000000000000092. PubMed PMID: 26049408.

Psychosis Prevention: A Modified Clinical High Risk Perspective From the Recognition and Prevention (RAP) Program.

Cornblatt BA, Carrión RE, Auther A, McLaughlin D, Olsen RH, John M, et al.. Psychosis Prevention: A Modified Clinical High Risk Perspective From the Recognition and Prevention (RAP) Program. Am J Psychiatry. 2015;172(10):986-94. DOI: 10.1176/appi.ajp.2015.13121686. PubMed PMID: 26046336.

Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review.

Samara MT, Leucht C, Leeflang MM, Anghelescu I-G, Chung Y-C, Crespo-Facorro B, et al. Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review. Am J Psychiatry. 2015;172(7):617-29. DOI: 10.1176/appi.ajp.2015.14101329. PubMed PMID: 26046338.